Most Recent

image: Lipids Take the Lead in Metastasis

Lipids Take the Lead in Metastasis

By | January 20, 2017

Researchers find diverse ways that the molecules can regulate cancer’s spread.

0 Comments

image: Unknown Protein Structures Predicted

Unknown Protein Structures Predicted

By | January 19, 2017

Metagenomic sequence data boosts the power of protein modeling software to yield hundreds of new protein structure predictions.

0 Comments

image: Replication Complications

Replication Complications

By | January 18, 2017

An initiative to replicate key findings in cancer biology yields a preliminary conclusion: it’s difficult.

0 Comments

Clostridium botulinum produces a transcription factor that can aggregate and self-propagate a prion-like form, leading to genome-wide changes in gene expression in E. coli, according to a study.

1 Comment

A team of scientists was unable to replicate controversial, high-profile findings published in 2011.

0 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

Children born to obese parents are at increased risk of failing motor development and cognitive tests, according to an NIH-led study.

0 Comments

image: Repurposing Existing Drugs for New Indications

Repurposing Existing Drugs for New Indications

By | January 1, 2017

An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.

1 Comment

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

image: Life Science Controversies of 2016

Life Science Controversies of 2016

By , , and | December 23, 2016

This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. German Scientists Resign from Elsevier Journals’ Editorial Boards
  3. Symmetrical Eyes Indicate Dyslexia
  4. Judge Recommends Ruling to Block Internet Access to Sci-Hub
RayBiotech